These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 14557030)

  • 1. Progress in functional genomics approaches to antifungal drug target discovery.
    De Backer MD; Van Dijck P
    Trends Microbiol; 2003 Oct; 11(10):470-8. PubMed ID: 14557030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional genomics approaches for the identification and validation of antifungal drug targets.
    De Backer MD; Van Dijck P; Luyten WH
    Am J Pharmacogenomics; 2002; 2(2):113-27. PubMed ID: 12083946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genomics strategies for antifungal drug discovery--from gene discovery to compound screening.
    Willins DA; Kessler M; Walker SS; Reyes GR; Cottarel G
    Curr Pharm Des; 2002; 8(13):1137-54. PubMed ID: 12052224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel strategies in antifungal lead discovery.
    Jiang B; Bussey H; Roemer T
    Curr Opin Microbiol; 2002 Oct; 5(5):466-71. PubMed ID: 12354552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomics, molecular targets and the discovery of antifungal drugs.
    Odds FC
    Rev Iberoam Micol; 2005 Dec; 22(4):229-37. PubMed ID: 16499416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genomic and genetic approaches for the identification of antifungal drug targets.
    Agarwal AK; Xu T; Jacob MR; Feng Q; Li XC; Walker LA; Clark AM
    Infect Disord Drug Targets; 2008 Mar; 8(1):2-15. PubMed ID: 18473903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimycotic drug discovery in the age of genomics.
    Cleary JD; Walker LA; Hawke RL
    Am J Pharmacogenomics; 2005; 5(6):365-86. PubMed ID: 16336002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fungal pathogens research: novel and improved molecular approaches for the discovery of antifungal drug targets.
    Tournu H; Serneels J; Van Dijck P
    Curr Drug Targets; 2005 Dec; 6(8):909-22. PubMed ID: 16375674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Yeast genomics and proteomics in drug discovery and target validation.
    Parsons AB; Geyer R; Hughes TR; Boone C
    Prog Cell Cycle Res; 2003; 5():159-66. PubMed ID: 14593709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genomic pathways to antifungal discovery.
    Monk BC; Cannon RD
    Curr Drug Targets Infect Disord; 2002 Dec; 2(4):309-29. PubMed ID: 12570738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomics and the prospects for the discovery of new targets for antibacterial and antifungal agents.
    Isaacson RE
    Curr Pharm Des; 2002; 8(13):1091-8. PubMed ID: 12052221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Recent progress in the study of fungal virulence factors and identification of new targets of anti-fungal drug using proteomic and transcriptomic analysis].
    Toyotome T; Watanabe A; Kamei K
    Nihon Rinsho; 2008 Dec; 66(12):2255-60. PubMed ID: 19069088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The antifungal pipeline: the need is established. Are there new compounds?
    Li D; She X; Calderone R
    FEMS Yeast Res; 2020 Jun; 20(4):. PubMed ID: 32353872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genomics and the development of new diagnostics and anti-Candida drugs.
    Weig M; Brown AJ
    Trends Microbiol; 2007 Jul; 15(7):310-7. PubMed ID: 17570672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antifungals discovery: an insight into new strategies to combat antifungal resistance.
    Fuentefria AM; Pippi B; Dalla Lana DF; Donato KK; de Andrade SF
    Lett Appl Microbiol; 2018 Jan; 66(1):2-13. PubMed ID: 29112282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A survey of yeast genomic assays for drug and target discovery.
    Smith AM; Ammar R; Nislow C; Giaever G
    Pharmacol Ther; 2010 Aug; 127(2):156-64. PubMed ID: 20546776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fun(gi)omics: Advanced and Diverse Technologies to Explore Emerging Fungal Pathogens and Define Mechanisms of Antifungal Resistance.
    Ball B; Langille M; Geddes-McAlister J
    mBio; 2020 Oct; 11(5):. PubMed ID: 33024032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting virulence: a new paradigm for antifungals.
    Gauwerky K; Borelli C; Korting HC
    Drug Discov Today; 2009 Feb; 14(3-4):214-22. PubMed ID: 19152839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Editorial: Current status and perspective on drug targets in tubercle bacilli and drug design of antituberculous agents based on structure-activity relationship.
    Tomioka H
    Curr Pharm Des; 2014; 20(27):4305-6. PubMed ID: 24245755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.